BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $13,101,000 | +41.0% | 11,000,000 | +41.0% | 0.07% | +37.7% |
| Q1 2017 | $9,291,000 | +63.1% | 7,800,000 | +62.5% | 0.05% | +55.9% |
| Q4 2016 | $5,697,000 | -68.5% | 4,800,000 | -66.9% | 0.03% | -75.7% |
| Q4 2014 | $18,067,000 | -47.7% | 14,500,000 | -53.8% | 0.14% | -48.9% |
| Q3 2014 | $34,568,000 | -13.0% | 31,400,000 | -16.7% | 0.27% | -9.9% |
| Q2 2014 | $39,724,000 | -35.8% | 37,700,000 | -32.3% | 0.30% | -39.4% |
| Q1 2014 | $61,916,000 | +13.4% | 55,700,000 | +9.9% | 0.50% | +10.1% |
| Q4 2013 | $54,594,000 | – | 50,700,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,950,000 | $6,146,000 | 4.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,943,000 | $39,192,000 | 0.73% |
| Sonora Investment Management, LLC | 4,670,000 | $4,791,000 | 0.50% |
| MIZUHO SECURITIES USA LLC | 5,900,000 | $6,096,000 | 0.36% |
| IRON Financial LLC | 430,000 | $446,000 | 0.33% |
| RWC Asset Management LLP | 7,300,000 | $7,528,000 | 0.32% |
| Calamos Advisors LLC | 49,525,000 | $51,243,000 | 0.28% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 5,777,000 | $5,977,000 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,721,000 | $5,896,000 | 0.18% |
| Calamos Wealth Management LLC | 1,240,000 | $1,283,000 | 0.17% |